Kalaris Therapeutics (KLRS) Operating Leases (2019 - 2026)
Kalaris Therapeutics (KLRS) posted Operating Leases of $1.05 million for Q2 2026, down 3.7% from the prior quarter.
Powered by 
Analysis
Kalaris Therapeutics (KLRS) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Kalaris Therapeutics' Operating Leases came in at $1.13 million.
- Annual Operating Leases shows a five-year compound annual growth rate of -27.0% (FY2020 to FY2025).
- In prior years, Kalaris Therapeutics' Operating Leases was $16.65 million in FY2023 (-41.0%), $28.22 million in FY2022 (+20.2%) and $23.48 million in FY2021 (+329.7%).
- The Q2 2026 figure stands as the lowest quarterly Operating Leases in data going back to Q4 2019.
- The strongest year-over-year quarter for Operating Leases in the past five years was Q2 2022, with growth of 367.7%; the weakest was Q2 2024, with a decline of 63.8%.
- According to Business Quant data, Operating Leases for the three prior quarters was $1.09 million (Q1 2026), $1.13 million (Q4 2025) and $1.17 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Kalaris Therapeutics | 44.52 Mn | -38.38 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.01 Mn |
| Jun 30, 2026 | 1.05 Mn |
| Mar 31, 2026 | 1.09 Mn |
| Dec 31, 2025 | 1.13 Mn |
| Sep 30, 2025 | 1.17 Mn |
| Jun 30, 2024 | 8.34 Mn |
| Mar 31, 2024 | 16.05 Mn |
| Dec 31, 2023 | 16.65 Mn |
| Sep 30, 2023 | 19.91 Mn |
| Jun 30, 2023 | 23.02 Mn |
| Mar 31, 2023 | 25.55 Mn |
| Dec 31, 2022 | 28.22 Mn |
| Sep 30, 2022 | 19.75 Mn |
| Jun 30, 2022 | 20.27 Mn |
| Mar 31, 2022 | 20.78 Mn |
| Dec 31, 2021 | 23.48 Mn |
| Sep 30, 2021 | 25.05 Mn |
| Jun 30, 2021 | 4.33 Mn |
| Mar 31, 2021 | 5.41 Mn |
| Dec 31, 2020 | 5.46 Mn |
API Access
Kalaris Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=KLRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "KLRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=KLRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();